Article
Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
Redox biology - 1 Dec 2015
Ryk Charlotta, Koskela Lotta Renström, Thiel Tomas, Wiklund N Peter, Steineck Gunnar, Schumacher Martin C, de Verdier Petra J
Abstract excerpt
PURPOSE: Bacillus Calmette-Guérin (BCG)-treatment is an established treatment for bladder cancer, but its mechanisms of action are not fully understood. High-risk non-muscle invasive bladder-cancer (NMIBC)-patients failing to respond to BCG-treatment have worse prognosis than those undergoing immediate radical cystectomy and identification of patients at risk for BCG-failure is of high priority. Several studies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
